Alkahest to Present at the Society for Neuroscience Annual Meeting

Monday, November 5, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Presentations highlight a novel multifactorial approach to treating neurodegenerative diseases

SAN CARLOS, Calif., Nov. 5, 2018 /PRNewswire/ -- Alkahest Inc. ("Alkahest"), a clinical-stage biotechnology company focused

on developing innovative therapies to treat age-related diseases, today announced upcoming presentations at the Society for Neuroscience 48th Annual Meeting held November 3 – 7, 2018 in San Diego. The Alkahest team will present recent preclinical data on the company's novel approaches to the treatment of neurodegenerative disorders today on November 5th and on November 7th.  

"Findings from these presentations add to the growing body of research supporting our hypothesis that factors in the plasma proteome can play an important modulatory role in neurodegenerative diseases, particularly cognitive dysfunction and neurodegeneration. This presents an entirely new opportunity for therapeutic interventions," said Steven Braithwaite, Ph.D., chief scientific officer of Alkahest.

Poster Presentation Title: Synergistic effects of a plasma fraction and exercise on neurogenesis  Presenter: I. GALLAGERDate: Monday, November 5, 2018Session Time:  8:00 a.m. – 12:00 p.m. PTSession: Neurogenesis and Gliogenesis: Neuronal Development I

Poster Presentation Title: Longitudinal characterization of plasma fraction efficacy on neurogenesis in aging mice  Presenter: R. A. ESTRADADate: Monday, November 5, 2018 Session Time: 8:00 a.m.12:00 p.m. PTSession: Neurogenesis and Gliogenesis: Neuronal Development I

Poster Presentation Title: Human plasma fraction prevents age-dependent decline in neuronal activity, neurogenesis, and neuroinflammation in C57BL6 micePresenter: M. K. CAMPBELLDate: Monday, November 5, 2018Session Time: 8:00 a.m.12:00 p.m. PTSession: Brain Wellness and Aging: Pharmacological and Non-Pharmacological Interventions

Presentation Title: Multi-modal impact of treatment with a human plasma protein fraction to enhance CNS functionPresenter: E. CZIRRDate: Monday, November 5, 2018Session Time: 1:00 p.m.2:45 p.m. PTSession: Brain Wellness and Aging: Systemic Factors and Brain Function

Presentation Title: Identification and characterization of a beneficial plasma fraction with long term efficacy in the CNS  Presenter: V. KHEIFETSDate: Monday, November 5, 2018Session Time: 1:00 p.m.2:45 p.m. PTSession: Brain Wellness and Aging: Systemic Factors and Brain Function

Poster Presentation Title: Treatment with a CCR3 antagonist rescues neuroinflammation and cognitive dysfunction in acute and chronic LPS models  Presenter: S. REGEDate: Wednesday, November 7, 2018Session Time: 8:00 a.m.12:00 p.m. PT Session: Neurotoxicity, Inflammation, and Neuroprotection: Neuroinflammation: Animal Models

Poster Presentation Title: Human Plasma Fraction reduces the detrimental effects of alpha-synuclein overexpression in mice  Presenter: C. TUNDate: Wednesday, November 7, 2018Session Time: 1:00 p.m.5:00 p.m. PT Session: Parkinson's Disease: Alpha-Synuclein: Models

About AlkahestAlkahest is a privately-held clinical-stage company based in the San Francisco Bay Area developing treatments for age-related diseases, with an emphasis on neurodegeneration — a key medical challenge for our generation. The company's breakthrough research has elucidated changes in the plasma proteome in healthy aging and age-related diseases, and demonstrated that factors in the blood plasma can be augmented or inhibited in order to reverse detrimental effects of aging in both normal aging and disease models in animals. Alkahest is developing novel plasma-based therapies in collaboration with Barcelona, Spain-based Grifols, a global healthcare company and leading producer of plasma therapies. For further information, see www.alkahest.com.

Contact Information:Joe McCrackenVice President Business DevelopmentAlkahest, Inc. jmccracken@alkahest.com

Media Contact:Michael TattoryLifeSci Public Relations mtattory@lifescipublicrelations.com

 

Cision View original content:http://www.prnewswire.com/news-releases/alkahest-to-present-at-the-society-for-neuroscience-annual-meeting-300743366.html

SOURCE Alkahest Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store